Anti-GAPDH Polyclonal Antibody | AB0049

Goat Anti-Human GAPDH IgG Polyclonal Antibody | AB0049 | Antibodies

Overview: Goat polyclonal to GAPDH (glyceraldehyde 3-phosphate dehydrogenase). GAPDH catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The enzyme exists as a tetramer of identical chains.

Other Names: glyceraldehyde 3-phosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, G3PD, GAPD, HGNC:4141, GAPDH antibody.

Other Names: glyceraldehyde 3-phosphate dehydrogenase, glyceraldehyde-3-phosphate dehydrogenase, G3PD, GAPD, HGNC:4141, GAPDH antibody.

Concentration: 2 mg/ml

Antibody Type: Primary

Target Type: Anti-GAPDH

Accession Number: ENSG00000111640

Host Species: Goat

Immunogen Species: Human

Immunogen Type: Recombinant protein

Immunogen: Purified recombinant peptide derived from within residues 240 aa to the C-terminus of human GAPDH produced in E. coli.

Isotype: IgG

Clonality: Polyclonal

Confirmed Reactive Species: Human, mouse, rat, fish, bovine, canine, chicken/avian, donkey, feline, goat, guinea pig, hamster, horse, porcine, rabbit, sheep, simian, other

Specificity Detail: Detects a band of 37 kDa by Western blot in the following human (293A, HMEC-1, U-118, HaCat), rat (TR-iBRB), mouse (AtT-20, Hepa), canine (D17) and monkey (COS-7) whole cell lysates.

Buffer: PBS, 20% glycerol and 0.05% sodium azide

Purification: Epitope affinity purified

Conjugation: Unconjugated

Format: N/A

Application: WB, IF, IHC-P, IHC-F

Concentration/Dilution: WB:1:500-1:5,000, IF:1:50-1:250, IHC-P:1:200-1:1,000, IHC-F:1:200-1:1,000

Storage: N/A

References: 1. Martins SGR, MSc Thesis, NOVA University of Lisbon, Portugal 2019, 2. Ferreira JV, Rosa Soares A, Ramalho JS, et al. PLoS One 2019 Oct. PMID:31613922, 3. Alenquer M, Vale-Costa S, Etibor TA, et al. Nat Commun 2019 Apr. PMID:30967547, 4. Sanzà P, Evans RD, Briggs DA, et al. J Cell Sci 2019 Apr. PMID:30898842, 5. Aires ID, Boia R, Rodrigues-Neves AC, et al. Glia 2019 Jan. PMID:30667095, 6. Barbeitos JP, MSc Thesis, University of Coimbra, Portugal 2018, 7. Alenquer M, Vale-Costa S, Sousa AL, et al. bioRxiv 410373; Sept 2018, 8. Alzahofi N, Robinson CL, Welz T, et al. bioRxiv 314153; May 2018, 9. Ribeiro ST, Tesio M, Ribot JC, et al. Leukemia 2017 Jul. PMID:27899804, 10. Santarino IB, Viegas MS, Domingues NS, et al. Sci Rep 2017 Jul. PMID:28724916, 11. Ribeiro STF, PhD Thesis, University of Lisbon, Portugal 2017, 12. Robinson CL, Evans RD, Briggs DA, et al. J Cell Sci 2017 May. PMID:28490438, 13. Ramalho AR, Toscano A, Pereira P. et al. Rev Port Cardiol 2017 May. PMID:28479269, 14. Vale-Costa S, Alenquer M, Sousa AL, et al. J Cell Sci 2016 Mar. PMID:26940915, 15. Encarnação M, Espada L, Escrevente C, et al. J Cell Biol 2016 Jun. PMID: 27325790, 16. Ferreira JV, Soares AR, Ramalho JS, et al. Sci Rep. 2015 May. PMID:25958982, 17. Ferreira RRS, MSc Thesis, University of Coimbra, Portugal 2015, 18. Paiva RA, MSc Thesis, University of Coimbra, Portugal 2015, 19. Casalou C, Seixas C, Portelinha A, et al. J Cell Sci 2014 Jun. PMID:24777479, 20. Ribeiro-Rodrigues TM, Catarino S, Marques C, et al. FASEB J 2014 Nov. PMID:25070368, 21. Moreiras HAF, MSc Thesis, University of Lisbon, Portugal 2014